NPS advice on mifepristone and misoprostol now available online

Following the TGA’s decision to register mifepristone (RU 486) and misoprostol for medical termination of pregnancy, NPS MedicineWise has published new advice for health professionals to help them understand these medicines and how to use them.
The advice from NPS outlines:
  • what the medicines are
  • who can prescribe them
  • availability of medicines
  • indications for use
  • dosing recommendations
  • safety issues
  • information for patients
  • links to additional resources.


Independent, evidence-based and not-for-profit, NPS MedicineWise enables better decisions about medicines and medical tests. We are funded by the Australian Government Department of Health and Ageing.